Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Keith Holley

Adult Reconstructive Orthopaedic Surgery Nampa, ID Medical Doctor

NPI 1386616183 CMS profile 857830

4424 E Flamingo Ave, Suite 110, Nampa, ID 83687

Open in the dashboard

General payments

$36,242

408 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Keith Holley of Nampa, ID is reported in the CMS Open Payments database as having received $36,242 across 408 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 73rd percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $10,419 55
2024 General $3,411 57
2023 General $4,862 62
2022 General $2,892 55
2021 General $8,211 64
2020 General $1,565 56
2019 General $4,882 59

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Keith Holley
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Keith Holley were reported at $10,419. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Keith Holley Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $4,882 $1,416 $292–$9,336 $163
2020 $1,565 $647 $141–$6,474 $114
2021 $8,211 $1,073 $211–$6,497 $132
2022 $2,892 $1,217 $236–$6,299 $149
2023 $4,862 $1,082 $246–$6,818 $160
2024 $3,411 $1,575 $323–$8,944 $164
2025 $10,419 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Total Joint Orthopedics, Inc. $35,228 391 payments
  2. Medacta USA, Inc. $282 5 payments
  3. Zimmer Biomet Holdings, Inc. $258 3 payments
  4. Orthalign Inc $119 1 payment
  5. Engage Uni, LLC $114 1 payment
  6. Stryker Corporation $100 1 payment
  7. Sawtooth Surgical Solutions Inc $39 1 payment
  8. Horizon Therapeutics plc $36 2 payments
  9. Think Surgical, Inc. $31 1 payment
  10. Lilly USA, LLC $21 1 payment
  11. Other $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $23,500 18 payments
  2. Food and Beverage $6,405 368 payments
  3. Royalty or License $6,222 21 payments
  4. Gift $114 1 payment
Products named General payments · program years 2019–2025
  1. Persona $202 2 payments
  2. ORTHALIGN PLUS $119 1 payment
  3. GMK $115 1 payment
  4. Engage Partial Knee System $114 1 payment
  5. MAKO $100 1 payment
  6. MOTO UNI $81 1 payment
  7. Robotics-Knees $56 1 payment
  8. GMK Sphere $54 1 payment
  9. PENNSAID $36 2 payments
  10. TMINI Miniature Robotic System $31 1 payment
  11. Other $79 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

192

Median for Orthopedic Surgery: 203

Drug cost

$738

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Tramadol Hcl Generic 27 $177
Meloxicam Generic 53 $149
Mupirocin Generic 15 $130
Amoxicillin Generic 67 $117
Gabapentin Generic 15 $99
Clindamycin Hcl Generic 15 $66

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 24 billing codes

Paid by Medicare

$101,293

Medicare's payments for the services billed

Medicare patients

166

Average age 73

Services billed

692

102 women, 64 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 67%
Depression 24%
Diabetes 18%
Atrial fibrillation 17%
Osteoporosis 17%
Chronic kidney disease 16%
Ischemic heart disease 12%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

408 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Idaho

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record